| 摘要 |
<p>Novel compounds of the structural formula (I) are activators of AMP-protein kinase and are useful in the treatment, prevention and suppression of diseases mediated by the AMPK-activated protein kinase. The compounds of the present invention are useful in the treatment of Type 2 diabetes, hyperglycemia, metabolic syndrome, obesity, hypercholesterolemia, and hypertension.</p> |
| 申请人 |
MERCK SHARP & DOHME CORP.;METABASIS THERAPEUTICS, INC. |
发明人 |
DANG, QUN;CHUNG, DE MICHAEL;GIBSON, TONY, S.;JIANG, HONGJIAN;CASHION, DANIEL, K.;BAO, JIANMING;LAN, PING;LU, HUAGANG;MAKARA, GERGELY, M.;ROMERO, F., ANTHONY;SEBHAT, IYASSU;WODKA, DARIUSZ |
